Acadia Healthcare (NASDAQ:ACHC) Lifted to Hold at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a sell rating to a hold rating in a research note issued to investors on Thursday, MarketBeat reports. Deutsche Bank Aktiengesellschaft currently has $70.00 target price on the stock.

A number of other brokerages have also issued reports on ACHC. TheStreet raised shares of Acadia Healthcare from a c rating to a b- rating in a research note on Monday, March 4th. TD Cowen upped their target price on Acadia Healthcare from $86.00 to $101.00 and gave the stock an outperform rating in a research report on Friday, March 1st. Mizuho increased their price objective on Acadia Healthcare from $77.00 to $84.00 and gave the stock a neutral rating in a report on Wednesday, March 6th. UBS Group boosted their target price on shares of Acadia Healthcare from $88.00 to $102.00 and gave the stock a buy rating in a research report on Wednesday, February 28th. Finally, Barclays started coverage on shares of Acadia Healthcare in a research note on Wednesday, March 6th. They issued an overweight rating and a $100.00 price objective for the company. Four research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and an average price target of $92.00.

Acadia Healthcare Trading Up 3.1 %

Shares of ACHC stock opened at $73.38 on Thursday. The stock has a fifty day moving average of $78.45 and a two-hundred day moving average of $77.67. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67. Acadia Healthcare has a 1 year low of $66.49 and a 1 year high of $87.77. The firm has a market capitalization of $6.78 billion, a PE ratio of -293.51, a price-to-earnings-growth ratio of 2.09 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.05. The firm had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. Acadia Healthcare’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.70 earnings per share. As a group, research analysts expect that Acadia Healthcare will post 3.57 EPS for the current year.

Insider Activity

In related news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the sale, the director now owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 2.80% of the company’s stock.

Institutional Investors Weigh In On Acadia Healthcare

Several large investors have recently modified their holdings of ACHC. Vanguard Group Inc. increased its position in shares of Acadia Healthcare by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock worth $689,065,000 after purchasing an additional 30,296 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Acadia Healthcare by 2.1% in the third quarter. Wellington Management Group LLP now owns 7,537,922 shares of the company’s stock valued at $529,991,000 after acquiring an additional 152,783 shares during the last quarter. William Blair Investment Management LLC grew its position in Acadia Healthcare by 0.3% during the 3rd quarter. William Blair Investment Management LLC now owns 3,058,916 shares of the company’s stock worth $215,072,000 after acquiring an additional 10,062 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in Acadia Healthcare by 1.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,258,459 shares of the company’s stock valued at $88,482,000 after purchasing an additional 13,765 shares in the last quarter. Finally, Avidity Partners Management LP boosted its stake in Acadia Healthcare by 61.8% in the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock worth $89,944,000 after purchasing an additional 441,692 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.